Skip to main content

Medical use of cannabis

This content has been automatically generated from the original PDF and some formatting may have been lost. Let us know if you find any major problems.

Text in this format is not official and should not be relied upon to extract citations or propose amendments. Please see the PDF for the official version of the document.

WQ.261/2023

WRITTEN QUESTION TO

THE MINISTER FOR ECONOMIC DEVELOPMENT, TOURISM, SPORT AND CULTURE BY DEPUTY R.J. WARD OF ST. HELIER CENTRAL

QUESTION SUBMITTED ON MONDAY 5th JUNE 2023

ANSWER TO BE TABLED ON MONDAY 12th JUNE 2023

Question

“In light of comments made at a recent public hearing, at which the Minister stated that developments in the cannabis industry in Jersey have been overseen by the Economic Development Unit, and that “Jersey’s reputation is pinned to the mast of high regulation and high quality”, will the Minister explain what regulation exists in Jersey to control the medical use of cannabis, and how such regulation reflects the World Health Organisation (WHO) approach to the regulation of cannabis as a medicine?”

Answer

The regulation and control of use of cannabis for medicinal purposes falls under the remit of the Minister for Health and Social Services and is managed via the following legislation:

Misuse of Drugs (Jersey) Law

Cannabis is a controlled drug in Class B of The Misuse of Drugs (Jersey) Law 1978 and a Schedule 1 controlled drug under the Misuse of Drugs (General Provisions) (Jersey) Order 2009

A cannabis-based product for medicinal use (CBPM) is controlled as a Schedule 2 controlled drug under the same order. This enables them to be used for medicinal purposes.

Only products which are produced to Good Manufacturing Practice (GMP) standards by a GMP certified manufacturer are classified as a CBPM under this legislation.

Medicines (Jersey) Law 1995

Additionally, Cannabis-based products for medicinal use (CBPMS) are controlled under the Medicines (Jersey) Law 1995. This law specifically regulates production, distribution and supply of all medicinal products including CBPMs.

The United Nations Single Convention on Narcotic Drugs, 1961 provides for the control of Cannabis under Articles 23 and 28. Jersey is required to comply with this convention as a named territory to the UK.